274 related articles for article (PubMed ID: 29459582)
1. Paeoniflorin Inhibits Receptor Activator for Nuclear Factor κB (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo.
Li Z; Li D; Chen X
Med Sci Monit; 2018 Feb; 24():1044-1053. PubMed ID: 29459582
[TBL] [Abstract][Full Text] [Related]
2. Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.
Hu B; Wu F; Shi Z; He B; Zhao X; Wu H; Yan S
J Cell Mol Med; 2019 Aug; 23(8):5762-5770. PubMed ID: 31225720
[TBL] [Abstract][Full Text] [Related]
3. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
Ihn HJ; Kim K; Cho HS; Park EK
Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
[TBL] [Abstract][Full Text] [Related]
4. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
5. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
[TBL] [Abstract][Full Text] [Related]
6. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
7. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
8. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
[TBL] [Abstract][Full Text] [Related]
9. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
[TBL] [Abstract][Full Text] [Related]
10. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling.
Zhai Z; Qu X; Li H; Yang K; Wan P; Tan L; Ouyang Z; Liu X; Tian B; Xiao F; Wang W; Jiang C; Tang T; Fan Q; Qin A; Dai K
Biomaterials; 2014 Aug; 35(24):6299-310. PubMed ID: 24816285
[TBL] [Abstract][Full Text] [Related]
11. Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-κb and Nfatc1 Activities.
Jiang C; Shang J; Li Z; Qin A; Ouyang Z; Qu X; Li H; Tian B; Wang W; Wu C; Wang J; Dai M
J Cell Physiol; 2016 Jan; 231(1):142-51. PubMed ID: 26060084
[TBL] [Abstract][Full Text] [Related]
12. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
[TBL] [Abstract][Full Text] [Related]
13. Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo.
Wei CM; Su YJ; Qin X; Ding JX; Liu Q; Song FM; Zong SH; Xu J; Zhou B; Zhao JM
Cell Physiol Biochem; 2018; 48(2):644-656. PubMed ID: 30025412
[TBL] [Abstract][Full Text] [Related]
14. Bulleyaconitine A prevents Ti particle-induced osteolysis via suppressing NF-κB signal pathway during osteoclastogenesis and osteoblastogenesis.
Zhang L; Feng M; Li Z; Zhu M; Fan Y; Chu B; Yuan C; Chen L; Lv H; Hong Z; Hong D
J Cell Physiol; 2018 Sep; 233(9):7067-7079. PubMed ID: 29388671
[TBL] [Abstract][Full Text] [Related]
15. Carnosol suppresses RANKL-induced osteoclastogenesis and attenuates titanium particles-induced osteolysis.
Li Y; Lin S; Liu P; Huang J; Qiu J; Wen Z; Yuan J; Qiu H; Liu Y; Liu Q; Zhou T; Luo P; Guo H; Ma Y; Guo D; Mo G; Tang Y; Xu L; Liang D; Xu J; Ding Y; Zhang S
J Cell Physiol; 2021 Mar; 236(3):1950-1966. PubMed ID: 32722851
[TBL] [Abstract][Full Text] [Related]
16. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
[TBL] [Abstract][Full Text] [Related]
17. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
[TBL] [Abstract][Full Text] [Related]
18. Taxifolin Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.
Zhang HQ; Wang YJ; Yang GT; Gao QL; Tang MX
Pharmacology; 2019; 103(1-2):101-109. PubMed ID: 30522105
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
20. Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.
Thummuri D; Naidu VGM; Chaudhari P
J Mol Med (Berl); 2017 Oct; 95(10):1065-1076. PubMed ID: 28674855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]